PA
IRWD icon

Perceptive Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Perceptive Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-102,957
Closed -$899K – 165
2015
Q3 		$899K Sell
102,957
-486,401
-83% -$4.54M 0.07% 98
2015
Q2 		$5.95M Buy
+589,358
New +$6.85M 0.36% 61

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Perceptive Advisors's IRWD Position: Q4 2015 in Review

Perceptive Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2015, closing a stake of 102,957 shares — an estimated $899K sold.

Perceptive Advisors first reported a position in IRWD in Q2 2015 and held it in 2 quarters. The position peaked at $5.95M in Q2 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q4 2015.

  • Perceptive Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Perceptive Advisors sold 102,957 Ironwood Pharmaceuticals shares in Q4 2015, an estimated $899K.
  • Perceptive Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Perceptive Advisors's Ironwood Pharmaceuticals position peaked at $5.95M in Q2 2015.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2015.

Based on Perceptive Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.